Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
FRIEDBERG, Jonathan W, MAHADEVAN, Daruka, FINGERT, Howard, DANAEE, Hadi, BERNSTEIN, Steven H, CEBULA, Erin, PERSKY, Daniel, LOSSOS, Izidore, AGARWAL, Amit B, JUNGAH JUNG, BURACK, Richard, XIAOFEI ZHOU, LEONARD, E. Jane
Published in Journal of clinical oncology (01.01.2014)
Published in Journal of clinical oncology (01.01.2014)
Get full text
Journal Article
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
Goldberg, Stuart L, Fenaux, Pierre, Craig, Michael D, Gyan, Emmanuel, Lister, John, Kassis, Jeannine, Pigneux, Arnaud, Schiller, Gary J, Jung, JungAh, Jane Leonard, E, Fingert, Howard, Westervelt, Peter
Published in Leukemia research reports (2014)
Published in Leukemia research reports (2014)
Get full text
Journal Article
Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial
Clayton, Anita H, Lasser, Robert, Parikh, Sagar V, Iosifescu, Dan V, Jung, JungAh, Kotecha, Mona, Forrestal, Fiona, Jonas, Jeffrey, Kanes, Stephen J, Doherty, James
Published in The American journal of psychiatry (01.09.2023)
Published in The American journal of psychiatry (01.09.2023)
Get full text
Journal Article
EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer
Bardia, Aditya, Aftimos, Philippe, Bihani, Teeru, Anderson-Villaluz, Alfred T, Jung, JungAh, Conlan, Maureen G, Kaklamani, Virginia G
Published in Future oncology (London, England) (01.10.2019)
Published in Future oncology (London, England) (01.10.2019)
Get full text
Journal Article
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study
Parikh, Sagar V, Aaronson, Scott T, Mathew, Sanjay J, Alva, Gustavo, DeBattista, Charles, Kanes, Stephen, Lasser, Robert, Bullock, Amy, Kotecha, Mona, Jung, JungAh, Forrestal, Fiona, Jonas, Jeff, Vera, Theresa, Leclair, Bridgette, Doherty, James
Published in Neuropsychopharmacology (New York, N.Y.) (01.01.2024)
Published in Neuropsychopharmacology (New York, N.Y.) (01.01.2024)
Get full text
Journal Article
Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
CERVANTES, Andres, ELEZ, Elena, PIERA, Adelaida, BLASCO, Inma, MANOS, Laura, PEREZ-FIDALGO, José-Alejandro, FINGERT, Howard, BASELGA, Jose, TABERNERO, Josep, RODA, Desamparados, ECSEDY, Jeffrey, MACARULLA, Teresa, VENKATAKRISHNAN, Karthik, ROSELLO, Susana, ANDREU, Jordi, JUNG, Jungah, SANCHIS-GARCIA, Juan Manuel
Published in Clinical cancer research (01.09.2012)
Published in Clinical cancer research (01.09.2012)
Get full text
Journal Article
Abstract OT1-04-04: EMERALD: A randomized, open-label, phase 3 trial to evaluate the efficacy and safety of elacestrant (RAD1901), a novel oral selective estrogen receptor degrader (SERD), vs investigator’s choice of endocrine therapy for ER+/HER2- advanced breast cancer following CDK4/6 inhibitor therapy
Aftimos, Philippe, Bardia, Aditya, Kaklamani, Virginia G, Lu, Janice, Bihani, Teeru, Jung, JungAh, Anderson-Villaluz, Alfred T, Conlan, Maureen G, Cortes, Javier
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies
Almhanna, Khaldoun, Kalebic, Thea, Cruz, Cristina, Faris, Jason E, Ryan, David P, Jung, JungAh, Wyant, Tim, Fasanmade, Adedigbo A, Messersmith, Wells, Rodon, Jordi
Published in Clinical cancer research (15.10.2016)
Published in Clinical cancer research (15.10.2016)
Get full text
Journal Article
Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures
Chung, Steve, Sinha, Saurabh R., Shah, Aashit, Stern, John M., Cheng, Hailong, Jung, JungAh, Grinnell, Todd, Blum, David
Published in Epilepsy research (01.07.2019)
Published in Epilepsy research (01.07.2019)
Get full text
Journal Article
Abstract PD7-07: Final analysis of phase 1 study of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer
Kaklamani, Virginia, Bardia, Aditya, Wilks, Sharon, Weise, Amy, Richards, Donald, Harb, Wael, Osborne, Cynthia, Wesolowski, Robert, Karuturi, Meghan, Conkling, Paul, Bagley, Rebecca, Jung, JungAh, Bihani, Teeru, Conlan, Maureen, Kabos, Peter
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
ELECTRONIC DEVICE FOR PROVIDING INTERNET OF THINGS SERVICE AND OPERATING METHOD THEREOF
KIM ARAM, PARK JUNHYUNG, PARK SANGHO, OH BYEONGIN, KIM BYUNGCHUL, JUNG JUNGAH, LEE DONGKYU, PARK SUNYOUNG, HAM DONGEUP
Year of Publication 16.04.2024
Get full text
Year of Publication 16.04.2024
Patent
ELECTRONIC DEVICE FOR PROVIDING INTERNET OF THINGS SERVICE, AND OPERATION METHOD THEREFOR
OH, Byeongin, KIM, Byungchul, LEE, Dongkyu, PARK, Junhyung, HAM, Dongeup, PARK, Sangho, KIM, Aram, PARK, Sunyoung, JUNG, Jungah
Year of Publication 11.04.2024
Get full text
Year of Publication 11.04.2024
Patent
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures
Abou-Khalil, Bassel, Klein, Pavel, Shah, Aashit, Ryvlin, Philippe, Specchio, Luigi M., Gama, Helena, Rocha, Francisco, Blum, David, Grinnell, Todd, Cheng, Hailong, Jung, JungAh
Published in Epilepsy research (01.11.2018)
Published in Epilepsy research (01.11.2018)
Get full text
Journal Article
Abstract P5-01-05: Genomic alterations detected by circulating tumor DNA and correlation with response to treatment with elacestrant, an oral selective estrogen receptor degrader, in phase 1 trials in postmenopausal women with ER+/HER2- advanced/metastatic breast cancer
Bihani, Teeru, Jung, JungAh, Patel, Hitisha K, Bardia, Aditya, Kabos, Peter, Kaklamani, Virginia, Jager, Agnes, Aftimos, Philippe, Wilks, Sharon, de Vries, Elisabeth, Harb, Wael, Richards, Donald, Weise, Amy, Wesolowski, Robert, van Oordt, Catharina CW Menke-van der Houven, Conkling, Paul, Neven, Patrick, Conlan, Maureen G
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Phase I Study of the Investigational Anti-Guanylyl Cyclase AntibodyDrug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies
Almhanna, Khaldoun, Kalebic, Thea, Cruz, Cristina, Faris, Jason E, Ryan, David P, Jung, JungAh, Wyant, Tim, Fasanmade, Adedigbo A, Messersmith, Wells, Rodon, Jordi
Published in Clinical cancer research (15.10.2016)
Published in Clinical cancer research (15.10.2016)
Get full text
Journal Article
ELECTRONIC DEVICE FOR PROVIDING MEDIA-BASED LIGHTING CONTROL SERVICES, OPERATION METHOD THEREFOR, AND STORAGE MEDIUM
OH, Byeongin, KIM, Byungchul, MIN, Jungho, KIM, Aram, PARK, Sunbi, PARK, Sunyoung, LEE, Jubong, JUNG, Jungah, PARK, Junhyung, EOM, Sooyong, PARK, Sangho, SEOL, Jaewoo, KIM, Yongjae, HONG, Kiwook
Year of Publication 07.03.2024
Get full text
Year of Publication 07.03.2024
Patent
MLN0264, an investigational antiguanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) malignancies: Phase I study
Cruz Zambrano, Cristina, Almhanna, Khaldoun, Messersmith, Wells A., Rodon Ahnert, Jordi, Ryan, David P., Faris, Jason Edward, Jung, JungAh, Fasanmade, Adedigbo, Wyant, Tim, Kalebic, Thea
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Mln0264, an Investigational, First-In-Class Antibody-Drug Conjugate Targeting Guanylyl Cyclase C (Gcc): First-In-Human Study in Patients with Advanced Gastrointestinal Malignancies
Messersmith, Wells, Almhanna, Khaldoun, Rodon, Jordi, Cruz, Cristina, Ryan, David, Jung, JungAh, Fasanmade, Adedigbo, Wyant, Tim, Kalebic, Thea
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)
O'Connor, Owen A., Özcan, Muhit, Jacobsen, Eric D., Roncero Vidal, Josep Maria, Trotman, Judith, Demeter, Judit, Masszi, Tamás, Pereira, Juliana, Ramchandren, Radhakrishnan, d'Amore, Francesco A., Foss, Francine, Kim, Won-Seog, Leonard, John P., Chiattone, Carlos Sérgio, Zinzani, Pier Luigi, Liu, Hua, Jung, JungAh, Zhou, Xiaofei, Leonard, E. Jane, Dansky Ullmann, Claudio, Shustov, Andrei R.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
MLN0264, an investigational, first-in-class antibody-drug conjugate (ADC) targeting guanylyl cyclase C (GCC): Phase I, first-in-human study in patients (pts) with advanced gastrointestinal (GI) malignancies expressing GCC
Almhanna, Khaldoun, Messersmith, Wells A., Rodon Ahnert, Jordi, Cruz, Cristina, Ryan, David P., Jung, JungAh, Fasanmade, Adedigbo, Wyant, Tim, Kalebic, Thea
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article